Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

DataMEDS AI, Inc. (MEDS) Balance Sheet

As of 2026-06-30 (10-Q), DataMEDS AI, Inc. (MEDS) reported total assets of $32.8M, total liabilities of $52.3M and shareholders' equity of -$19.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $2.5M. Long-term debt: $31.8M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MEDSDataMEDS AI, Inc.Follow MEDS — free
Medical Distribution · Healthcare
—
Price chart with a free account
Market cap
6.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
18 Nov, in 25 days
LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents0.01.00.02.5
Receivables——1.11.2
Inventory—9.51.61.5
Current assets0.315.22.85.6
Total assets0.357.330.532.8
Current liabilities2.938.029.839.4
Long-term debt—23.423.531.8
Short-term debt0.411.910.919.2
Total liabilities3.250.642.952.3
Shareholders' equity-2.96.7-12.4-19.5

USD millions · SEC XBRL

DataMEDS AI, Inc. — questions

How much cash does DataMEDS AI, Inc. have?
$2.5M in cash and cash equivalents as of 2026-06-30.
How much debt does DataMEDS AI, Inc. have?
$31.8M of long-term debt and $19.2M due within a year as of 2026-06-30.
What are DataMEDS AI, Inc.'s total assets?
$32.8M as of 2026-06-30.
What is DataMEDS AI, Inc.'s shareholders' equity?
-$19.5M as of 2026-06-30.

Every figure on this page comes from DataMEDS AI, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.